Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

NiQuitin targets smokers' New Year resolutions

Perrigo aims to assist smokers resolved to quit smoking in the New Year with its range of NiQuitin products.

The manufacturer claimed patients can improve their chances of quitting smoking by combining a nicotine patch with gum or a lozenge.

Perrigo, which launched its Extra Fresh Mint medicated chewing gum last year, said the brand “aims to empower pharmacists during this peak time”.

Perrigo senior marketing director Holly Turner said: “Many of us set new goals in January, so it is inevitably a big moment for people to try and give up smoking.”

“NiQuitin aims to provide pharmacists with the knowledge and materials to offer customers the best solution throughout their journey to quit, not just in January but throughout the year,” she added.

The NiQuitin range includes:

  • NiQuitin Minis Mint Lozenges (1.5mg and 4mg) single pack – RRP: £5.49
  • NiQuitin Minis Mint Lozenges (1.5mg and 4mg) triple pack – RRP: £14.99
  • NiQuitin Clear (7mg, 14mg and 21mg) and NiQuitin Pre-Quit (21mg) patches – RRP: £15.63
  • NiQuitin Extra Fresh Mint 30-piece pack of gum (2mg and 4mg) – RRP: £6.66
  • NiQuitin Extra Fresh Mint 100-piece pack of gum (2mg and 4mg) – RRP: £15.23
  • NiQuitin Extra Fresh Mint 200-piece pack of gum (2mg and 4mg) – RRP: £26.66

To order, contact 0800 1216909

Do you see an increase in patients quitting smoking in the new year?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD009114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel